Abstract
Purpose
The aim of this paper is to analyze the impact of prior breast cancer (BC) on mode of delivery and pregnancy-associated disorders.
Methods
A database from 262 German gynecological practices including 289,712 women between the ages of 18 and 45 with documented pregnancies between 2000 and 2014 was used to search for patients with a history of BC up to 10 years prior to pregnancy. A total of 165 patients with a history of BC were found and matched with 165 patients without a history of any cancer (1:1) by age, physician, obesity, and documented referral to a fertility center up to 12 months before the index pregnancy. The impact of prior BC on the mode of delivery and pregnancy-associated disorders was analyzed using Cox regression models.
Results
The mean maternal age at first visit was 34.6 years in both groups. The early and late pregnancy loss was significantly reduced (17.7 versus 29.9%, OR 0.50) and delivery of a live-born child more frequent (82.3 versus 70.1%, OR 2.00) in women who had had BC than in controls. Furthermore, preterm contractions without preterm birth were less frequent in women with BC compared to controls (9.2 versus 18.9%, OR 0.43). No significant differences were found for other pregnancy complications, such as suspected fetal growth restriction, genito-urinary infections, fetal malpresentation, gestational diabetes, pre-eclampsia, or breastfeeding issues.
Conclusions
Based on the decreased rate of early and late pregnancy loss and the absence of significant differences in most documented pregnancy-associated disorders, women with the previous BC can be assured of the possibility of a good outcome on a subsequent pregnancy.
Similar content being viewed by others
References
Allison JL, Sherwood RS, Schust DJ (2011) Management of first trimester pregnancy loss can be safely moved into the office. Rev Obstet Gynecol 4:5–14
Azim HA Jr, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H, Peccatori FA (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer 47:74–83. doi:10.1016/j.ejca.2010.09.007
Azim HA, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen M-B et al (2013) Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J. Clin Oncol 31:73–79. doi:10.1200/JCO.2012.44.2285
Becher H, Kostev K, Schröder-Bernhardi D (2009) Validity and representativeness of the “Disease Analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617–
de Bree E, Makrigiannakis A, Askoxylakis J, Melissas J, Tsiftsis DD (2010) Pregnancy after breast cancer. A comprehensive review. J Surg Oncol 101:534–542. doi:10.1002/jso.21514
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717. doi:10.1016/S0140-6736(05)66544-0
Gelber S, Coates AS, Goldhirsch A, Castiglione-Gertsch M, Marini G, Lindtner J, Edelmann DZ, Gudgeon A, Harvey V, Gelber RD et al (2001) Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19:1671–1675
Harvey JC, Rosen PP, Ashikari R, Robbins GF, Kinne DW (1981) The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy. Surg Gynecol Obstet 153:723–725
Hickey M, Peate M, Saunders CM, Friedlander M (2009) Breast cancer in young women and its impact on reproductive function. Hum Reprod Update 15:323–339. doi:10.1093/humupd/dmn064
Ives A, Saunders C, Bulsara M, Semmens J (2007) Pregnancy after breast cancer: population based study. BMJ 334:194. doi:10.1136/bmj.39035.667176.55
Jacob L, Hadji P, Kostev K (2016) Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in Germany. J Geriatr Oncol. doi:10.1016/j.jgo.2016.03.001
Kalousidou N, Kyvernitakis I, Waehlert L, Engelhard J, Kostev K, Ziller V (2015) Pregnancy after breast cancer in germany—results of a retrospective database analysis. Z Für Geburtshilfe Neonatol 219:176–180. doi:10.1055/s-0034-1395539
Kang D-H, Weaver MT, Park N-J, Smith B, McArdle T, Carpenter J (2009) Significant impairment in immune recovery following cancer treatment. Nurs Res 58:105–114. doi:10.1097/NNR.0b013e31818fcecd
Kroman N, Jensen M-B, Wohlfahrt J, Ejlertsen B, Danish Breast Cancer Cooperative Group (2008) Pregnancy after treatment of breast cancer—a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol Stockh Swed 47:545–549. doi:10.1080/02841860801935491
Litton JK, Warneke CL, Hahn KM, Palla SL, Kuerer HM, Perkins GH, Mittendorf EA, Barnett C, Gonzalez-Angulo AM, Hortobágyi GN et al (2013) Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist 18:369–376. doi:10.1634/theoncologist.2012-0340
Mignot L, Morvan F, Berdah J, Querleu D, Laurent JC, Verhaeghe M, Fontaine F, Marin JL, Gorins A, Marty M (1986) Pregnancy after treated breast cancer. Results of a case–control study. Presse Médicale Paris Fr 1983 15:1961–1964
Mor G, Cardenas I (2010) The immune system in pregnancy: a unique complexity. Am J Reprod Immunol NY N 1989 63:425–433. doi:10.1111/j.1600-0897.2010.00836.x
Mueller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR (2003) Childbearing and survival after breast carcinoma in young women. Cancer 98:1131–1140. doi:10.1002/cncr.11634
Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, Gelber R, Goldhirsch A, Breast International Group (2011) North American Breast Cancer Group Endocrine Working Group: pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat 129:309–317. doi:10.1007/s10549-011-1643-7
Raphael J, Trudeau ME, Chan K (2014) Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature. Curr Oncol 22:8–18
Sankila R, Heinävaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 170:818–823
Valentini A, Lubinski J, Byrski T, Ghadirian P, Moller P, Lynch HT, Ainsworth P, Neuhausen SL, Weitzel J, Singer CF et al (2013) The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat 142:177–185. doi:10.1007/s10549-013-2729-1
Verma R, Foster RE, Horgan K, Mounsey K, Nixon H, Smalle N, Hughes TA, Carter CRD (2016) Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer. Breast Cancer Res BCR 18:10. doi:10.1186/s13058-015-0669-x
World Cancer Research Fund International (2015) Breast cancer statistics [Internet]. http://www.wcrf.org. Accessed on 16 Oct 2003
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Louis Jacob declares that he has no conflict of interest. Karel Kostev declares that he has no conflict of interest. Matthias Kalder declares that he has no conflict of interest. Birgit Arabin declares that she has no conflict of interest.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Rights and permissions
About this article
Cite this article
Jacob, L., Kalder, M., Arabin, B. et al. Impact of prior breast cancer on mode of delivery and pregnancy-associated disorders: a retrospective analysis of subsequent pregnancy outcomes. J Cancer Res Clin Oncol 143, 1069–1074 (2017). https://doi.org/10.1007/s00432-017-2352-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-017-2352-3